PlainRecalls
No agency classActive

CPSC recall · Reported July 6, 2018

Sandoz and Novartis Recall Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Closure Requirements

The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.

Recall #
18183
Affected scope
About 470,000
Compiled from official public sources by the publisher.
Verify with CPSC →
View my saved recalls

Sandoz Inc., of Princeton, N.j. recalled This recall involves blister packages of prescription drugs from Novartis and Sandoz. The….

Sandoz and Novartis Recall Prescription Drug Blister Packages Due to Failure to Meet Chil… was recalled by Sandoz Inc., of Princeton, N.j. in July 6, 2018. Reason: The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, po…. Remedy: Consumers should immediately secure the blister cards to keep them out of the sight and r…. Verify recall #18183 with the CPSC before acting.

The recall

Sandoz Inc., of Princeton, N.j. issued this CPSC recall-The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, po….

None
agency class
July 6, 2018
reported

Sourced from official CPSC enforcement records. Verify recall #18183 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. Consumers holding this product should act on the agency's documented remedy above rather than relying on general guidance.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,472 drugs & medications recalls on record

05001,0001,5002,000 2006201220152018202120242026 448

Product description

This recall involves blister packages of prescription drugs from Novartis and Sandoz. The drugs are packaged with 3 to 10 tablets per blister card. The recalled Novartis prescription blister packages have "Novartis," the name of the drug, dosage, NDC, lot number and expiration date printed on the cartons and the blister cards. The recall includes the following: Recalled Novartis Prescription Drugs NDC Numbers Tablet Strength Carton Configuration Lot Numbers Expiration Date Zofran ODT® 0078-0679-61 0078-0679-19 4 mg 30 count: 3 cards with 10 tablets each 1657088 Dec 2019 Zofran ODT® 0078-0680-61 0078-0680-19 8 mg 30 count: 3 cards with 10 tablets each 1641546 Oct 2019 Entresto® (sacubitril/valsartan) 0078-0659-61 0078-0659-35 24 mg/ 26 mg 100 count: 10 cards with 10 tablets each FX000005 FX000004 FX000003 F0010 F0009 F0007 Apr 2020 Apr 2020 Sep 2019 Nov 2018 Aug 2018 Jul 2018 Entresto® (sacubitril/valsartan) 0078-0777-61 0078-0777-35 49 mg/ 51 mg 100 count: 10 cards with 10 tablets each FX000001 F0006 F0005 F0004 Dec 2019 Oct 2019 Aug 2019 Oct 2018 Entresto® (sacubitril/valsartan) 0078-0696-61 0078-0696-35 97 mg/ 103 mg 100 count: 10 cards with 10 tablets each FX000002 F0007 F0006 F0005 F0004 Mar 2020 Feb 2020 Dec 2019 Dec 2018 Oct 2018 The recalled Sandoz prescription blister packages have "Sandoz," the name of the drug, dosage, NDC and lot number printed on the cartons and the blister cards. Lot numbers are listed at www.us.sandoz.com/patients-customers/product-safety-notices. The recall includes the following: Recalled Sandoz Prescription Drugs Tablet Strength NDC Numbers Carton Configuration Azithromycin Tablets 250 mg 0781-5776-06 0781-5776-69 50 count: 5 cards with 10 tablets each Donepezil ODT Tablets 5 mg 0781-5276-06 0781-5276-64 30 count: 3 cards with 10 tablets each Donepezil ODT Tablets 10 mg 0781-5277-06 0781-5277-64 30 count: 3 cards with 10 tablets each Haloperidol Tablets 0.5 mg 0781-1391-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 1 mg 0781-1392-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 2 mg 0781-1393-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 5 mg 0781-1396-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 10 mg 0781-1397-13 100 count: 10 cards with 10 tablets each Imipramine HCl Tablets 25 mg 0781-1764-13 100 count: 10 cards with 10 tablets each Imipramine HCl Tablets 50 mg 0781-1766-13 100 count: 10 cards with 10 tablets each Isosorbide Dinitrate (ISDN) Tablets 10 mg 0781-1556-13 100 count: 10 cards with 10 tablets each Isosorbide Dinitrate (ISDN) Tablets 20 mg 0781-1695-13 100 count: 10 cards with 10 tablets each Naratriptan Tablets 2.5 mg 0781-5527-06 0781-5527-37 9 count: 1 card with 9 tablets Ondansetron Tablets 8 mg 0781-1681-33 3 count: 1 card with 3 tablets Ondansetron ODT 4 mg 0781-5238-06 0781-5238-64 30 count: 3 cards with 10 tablets each Ondansetron ODT 8 mg 0781-5239-06 0781-5239-64 30 count: 3 cards with 10 tablets each Ondansetron ODT 8 mg 0781-5239-06 0781-5239-80 10 count: 1 card with 10 tablets Perphenazine Tablets 2 mg 0781-1046-13 100 count: 10 cards with 10 tablets each Perphenazine Tablets 4 mg 0781-1047-13 100 count: 10 cards with 10 tablets each Perphenazine Tablets 8 mg 0781-1048-13 100 count: 10 cards with 10 tablets each Risperidone ODT 0.5 mg 0781-5310-06 0781-5310-08 28 count: 7 cards with 4 tablets each Risperidone ODT 1 mg 0781-5311-06 0781-5311-08 28 count: 7 cards with 4 tablets each Risperidone ODT 2 mg 0781-5312-06 0781-5312-08 28 count: 7 cards with 4 tablets each Risperidone ODT 3 mg 0781-5313-06 0781-5313-08 28 count: 7 cards with 4 tablets each Risperidone ODT 4 mg 0781-5314-06 0781-5314-08 28 count: 7 cards with 4 tablets each

Reason for recall

The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.

Remedy, what to do

Consumers should immediately secure the blister cards to keep them out of the sight and reach of children and contact Novartis or Sandoz for further instructions. Novartis and Sandoz advise that consumers should continue to use the medication as directed once the blister packages are secured.

Recall Profile

Structured summary of the CPSC recall record
Attribute Value
Agency U.S. Consumer Product Safety Commission
Severity class Not classified by agency
Status Active
Recall number 18183
Date reported July 6, 2018
Date initiated July 6, 2018
Recalling firm Sandoz Inc., of Princeton, N.j.
Affected scope About 470,000
Distribution Not disclosed
Official source CPSC notice →

Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.

What to do with this recall

Consumers should immediately secure the blister cards to keep them out of the sight and reach of children and contact Novartis or…

  • Check the recall number (18183) and product description against the item you own. Search the archive
  • Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼
This recall involves blister packages of prescription drugs from Novartis and Sandoz. The drugs are packaged with 3 to 10 tablets per blister card. The recalled Novartis prescription blister packages have "Novartis," the name of the drug, dosage, NDC, lot number and expiration date printed on the cartons and the blister cards. The recall includes the following: Recalled Novartis Prescription Drugs NDC Numbers Tablet Strength Carton Configuration Lot Numbers Expiration Date Zofran ODT® 0078-0679-61 0078-0679-19 4 mg 30 count: 3 cards with 10 tablets each 1657088 Dec 2019 Zofran ODT® 0078-0680-61 0078-0680-19 8 mg 30 count: 3 cards with 10 tablets each 1641546 Oct 2019 Entresto® (sacubitril/valsartan) 0078-0659-61 0078-0659-35 24 mg/ 26 mg 100 count: 10 cards with 10 tablets each FX000005 FX000004 FX000003 F0010 F0009 F0007 Apr 2020 Apr 2020 Sep 2019 Nov 2018 Aug 2018 Jul 2018 Entresto® (sacubitril/valsartan) 0078-0777-61 0078-0777-35 49 mg/ 51 mg 100 count: 10 cards with 10 tablets each FX000001 F0006 F0005 F0004 Dec 2019 Oct 2019 Aug 2019 Oct 2018 Entresto® (sacubitril/valsartan) 0078-0696-61 0078-0696-35 97 mg/ 103 mg 100 count: 10 cards with 10 tablets each FX000002 F0007 F0006 F0005 F0004 Mar 2020 Feb 2020 Dec 2019 Dec 2018 Oct 2018 The recalled Sandoz prescription blister packages have "Sandoz," the name of the drug, dosage, NDC and lot number printed on the cartons and the blister cards. Lot numbers are listed at www.us.sandoz.com/patients-customers/product-safety-notices. The recall includes the following: Recalled Sandoz Prescription Drugs Tablet Strength NDC Numbers Carton Configuration Azithromycin Tablets 250 mg 0781-5776-06 0781-5776-69 50 count: 5 cards with 10 tablets each Donepezil ODT Tablets 5 mg 0781-5276-06 0781-5276-64 30 count: 3 cards with 10 tablets each Donepezil ODT Tablets 10 mg 0781-5277-06 0781-5277-64 30 count: 3 cards with 10 tablets each Haloperidol Tablets 0.5 mg 0781-1391-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 1 mg 0781-1392-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 2 mg 0781-1393-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 5 mg 0781-1396-13 100 count: 10 cards with 10 tablets each Haloperidol Tablets 10 mg 0781-1397-13 100 count: 10 cards with 10 tablets each Imipramine HCl Tablets 25 mg 0781-1764-13 100 count: 10 cards with 10 tablets each Imipramine HCl Tablets 50 mg 0781-1766-13 100 count: 10 cards with 10 tablets each Isosorbide Dinitrate (ISDN) Tablets 10 mg 0781-1556-13 100 count: 10 cards with 10 tablets each Isosorbide Dinitrate (ISDN) Tablets 20 mg 0781-1695-13 100 count: 10 cards with 10 tablets each Naratriptan Tablets 2.5 mg 0781-5527-06 0781-5527-37 9 count: 1 card with 9 tablets Ondansetron Tablets 8 mg 0781-1681-33 3 count: 1 card with 3 tablets Ondansetron ODT 4 mg 0781-5238-06 0781-5238-64 30 count: 3 cards with 10 tablets each Ondansetron ODT 8 mg 0781-5239-06 0781-5239-64 30 count: 3 cards with 10 tablets each Ondansetron ODT 8 mg 0781-5239-06 0781-5239-80 10 count: 1 card with 10 tablets Perphenazine Tablets 2 mg 0781-1046-13 100 count: 10 cards with 10 tablets each Perphenazine Tablets 4 mg 0781-1047-13 100 count: 10 cards with 10 tablets each Perphenazine Tablets 8 mg 0781-1048-13 100 count: 10 cards with 10 tablets each Risperidone ODT 0.5 mg 0781-5310-06 0781-5310-08 28 count: 7 cards with 4 tablets each Risperidone ODT 1 mg 0781-5311-06 0781-5311-08 28 count: 7 cards with 4 tablets each Risperidone ODT 2 mg 0781-5312-06 0781-5312-08 28 count: 7 cards with 4 tablets each Risperidone ODT 3 mg 0781-5313-06 0781-5313-08 28 count: 7 cards with 4 tablets each Risperidone ODT 4 mg 0781-5314-06 0781-5314-08 28 count: 7 cards with 4 tablets each. Recalled by Sandoz Inc., of Princeton, N.j.. Units affected: About 470,000.
Why was this product recalled? ▼
The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.
What should consumers do? ▼
Consumers should immediately secure the blister cards to keep them out of the sight and reach of children and contact Novartis or Sandoz for further instructions. Novartis and Sandoz advise that consumers should continue to use the medication as directed once the blister packages are secured.
Which agency issued this recall? ▼
This recall was issued by the CPSC on July 6, 2018. CPSC does not publish a hazard classification for this recall. Recall number: 18183.
How do I report an injury from a recalled product? ▼
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.

Nationwide recalls with similar severity or category timing

Consumer-product notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade, closest by report date among other firms and states.

Camso Recalls Dirt to Snow Bike Conversio… 2018-07-06 fentanyl Citrate USP 5 mcg in 0.9% Sodium… 2018-07-04 Meyer Lemon Chia Muffin, 4-pack, packaged… 2018-07-04 Blueberry Buckwheat Muffin, 4-pack, packa… 2018-07-04

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Belly Fat Reducer + Energy Booster and St… 2018-07-04 Blood & Internal Cleanser, Dietary Supple… 2018-07-04 Irinotecan Hydrochloride Injection, USP, … 2018-07-11 Irinotecan Hydrochloride Injection, USP, … 2018-07-11

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: CPSC, reported July 6, 2018. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026